Bringing Specificity to Treatment of Disease

Affibody is a Swedish biotech company focused on developing next generation products for therapy, diagnostic imaging, and other applications based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

Affibody® molecules are small and robust high affinity protein molecules that can be engineered to bind specifically to a large number of target proteins. The company also offers access to its proprietary albumin binding technology, Albumod™, for extended plasma half life of protein and peptide based drugs.

 
View an animation of how Affibody® molecules will enable cancer specialists to locate and treat tumors and metastases!